Core Viewpoint - Shineco, Inc. has successfully closed its underwritten public offering of 1,869,160 shares at a price of 2 million in gross proceeds before expenses [1]. Group 1: Offering Details - The public offering consisted of 1,869,160 shares of common stock priced at 2 million [1]. - The underwriters have a 45-day option to purchase an additional 280,374 shares at the public offering price to cover over-allotments [1]. - EF Hutton LLC served as the sole book-running manager for this offering [1]. Group 2: Regulatory Information - The common stock was offered under an effective shelf registration statement on Form S3, filed with the SEC and declared effective on June 10, 2022 [2]. - A prospectus supplement detailing the terms of the public offering was filed with the SEC on July 15, 2024 [2]. Group 3: Company Overview - Shineco, Inc. focuses on providing safe, efficient, and high-quality health and medical products and services, aiming to improve the quality of life [4]. - The company has developed 33 vitro diagnostic reagents and related medical devices and also produces and sells healthy and nutritious foods [4].
Shineco Announces Closing of $2 Million Underwritten Public Offering